McKesson and Clayton Dubilier & Rice agreed Tuesday to take Option Care Health private in a $5.8 billion transaction, removing the largest U.S. home infusion therapy provider from public markets six weeks before Medicare reimbursement rates reset for 2025. The consortium is paying a premium to lock in margin expansion that began when Option Care consolidated nine regional providers between 2019 and 2022, then spent three years integrating billing systems that now process $4.2 billion in annual revenue across 340 infusion sites.
The deal structure pairs McKesson's specialty drug distribution network with CD&R's healthcare services portfolio, which already includes surgical center operator SCA Health and behavioral health provider Promise Healthcare. Option Care's patient count grew 23% year-over-year through Q2 2024, driven by referrals from hospital systems that prefer outsourcing complex infusions to avoid staffing costs. The company handles immunoglobulin therapy, specialty oncology drugs, and anti-infectives that require clinical oversight but not inpatient beds. McKesson will contribute its existing specialty pharmacy relationships and supply chain infrastructure. CD&R will manage operational buildout, likely targeting 150-200 additional sites in underserved suburban markets where hospital discharges are rising but infusion capacity has not kept pace.
The transaction removes public market pressure on Option Care's margin timing. The company spent $180 million on nurse recruitment and retention between 2022 and 2024, compressing EBITDA margins to 11.4% even as patient volumes climbed. Private ownership allows the consortium to absorb short-term labor costs while Medicare's updated Durable Medical Equipment rate schedule takes effect in January. Industry participants expect the new rates to lift reimbursement for high-acuity infusions by 6-8%, which would flow directly to Option Care's bottom line without quarterly earnings call scrutiny. McKesson also gains control over a referral channel for its specialty drug portfolio, which generated $79 billion in revenue last fiscal year but faces margin pressure from biosimilar competition in oncology. Vertical integration with a captive infusion network allows McKesson to defend specialty pharma pricing by bundling distribution with clinical administration.
Allocators should monitor three developments. First, whether CD&R begins acquiring smaller regional infusion providers within 90-120 days to accelerate site density in Texas, Florida, and North Carolina, where Option Care holds less than 15% market share. Second, McKesson's disclosure of cross-selling metrics in its Q3 earnings call, expected late January, will reveal how quickly specialty drug volume migrates to Option Care's network. Third, watch for rival distributors AmerisourceBergen and Cardinal Health to announce competing infusion partnerships or acquisitions before the Medicare rate reset creates a 12-18 month window of elevated margins that justifies paying premiums for similar assets.
The consortium is paying 14.2x trailing EBITDA for a business that will likely generate 16-18% EBITDA margins within two years if nurse turnover stabilizes and reimbursement rates hold. McKesson's specialty distribution unit already refers $1.1 billion in annual drug volume to third-party infusion providers, which now shifts in-house. CD&R's last comparable healthcare services exit, surgical center operator Covenant Health, returned 2.8x over five years by consolidating fragmented regional operators and optimizing payer contracting. The same playbook applies here, except the regulatory tailwind from Medicare rate increases reduces execution risk. The deal closes in Q1 2025, subject to HSR clearance that should process cleanly given the consortium is not acquiring a direct competitor to McKesson's existing businesses.
The takeaway
McKesson and CD&R are paying $5.8B to capture infusion therapy margin expansion ahead of Medicare rate resets and defend specialty drug distribution through vertical integration.
Editorial & Disclosure Notice: This article was written with artificial intelligence from public sources and is published without individual human review. Artificial intelligence and other digital tools are also used for research, analysis, editing, formatting, and production. Errors, omissions, outdated information, or inaccuracies may occur. References to companies, brands, products, services, organizations, or individuals are for informational and editorial purposes and do not imply endorsement, sponsorship, affiliation, partnership, or approval unless expressly stated. All trademarks and other intellectual property remain the property of their respective owners. Opinions, analysis, estimates, and commentary are informational only and should not be construed as financial, investment, legal, tax, medical, procurement, or other professional advice. Information may be corrected, clarified, or updated after publication. Corrections or removal requests: jenny@pops4.com.
Want the 60-second program for your specific event?
Enter your event and email — we build it and send the branded proposal before lunch. No obligation.
The branded-identity layer Chiefs of Staff and heritage CMOs route through — your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.
200+authorized brands
70,000products · virtual proof on each
9 deskspublishing daily
1997one house, since
70,000 SKUs · virtual proof in 60 seconds · no platform fee · blind-shipped · ASI #217876
Your next customer won't visit your website. Their AI will.
AI assistants have quietly taken over the first step of buying — they answer from catalogs they can read and shortlist whoever can actually ship. Two questions now decide whether you exist to that buyer: can a machine read your catalog, and can you fulfill the order. Most brands fail one or both and never find out why the orders went elsewhere. The winners of this shift aren't the loudest. They're the most readable. Build for the machine that's about to do the shopping.
Built by the craft floor — apparel, media, packaging, and secure print.
This trade runs on hands, not desks. Imprint manufacturing & Komori heritage press through approved vendors · Canon high-speed secure-media operations is a craft floor — genuine Six Sigma discipline applied to ink, thread, foil, and registration, where a hundredth of an inch is the difference between a brand that reads serious and one that reads cheap. POPS4 is built by exactly those operators: independent, boots-on-the-ground engineers who carry their own book, read a client in microseconds, and put their name on every run. Beyond our own Virginia Beach floor, we work with a vetted network of craft manufacturers across the US — each meeting the highest excellence in QC standards in the industry, each a specialist in its own discipline — so apparel, hard-goods imprinting, media manufacturing, packaging, and secure printing all go to the bench built for them, coordinated from one accountable hub. Short-run from twenty-five units, volume to five hundred thousand. Two hundred authorized national brands, seventy thousand SKUs with virtual proofing on every one. Art archived for instant reorders. Net-thirty corporate terms, NDA-standard white-label — your name on the work, or none at all.
Strategy, positioning, identity, creative, and messaging — wired into an AI system that publishes and distributes on its own. Nine editorial desks generate the authority, the production house ships the physical proof, and the attribution layer tells you which post sold which SKU. What you get is an operating layer — content, catalog, and order path under one roof — that keeps working whether or not you are in the room. Built for principals who would rather own the machine than rent the agency.
Named-account programs — one desk, quiet delivery, NDA-standard.
One point of contact who already knows the file, so nothing restarts from zero between engagements. The work ships blind, under NDA, with your name on it or none at all. Built for single-family offices, heritage-house CMOs, sports-ownership groups, and the agencies that white-label our production. The relationship is the product; the merch is the proof of it.
SFO · Chief of Staff desk. Principal household, properties, aircraft, yacht, calendar, philanthropy — one file.
Shop seventy thousand products. Virtual proof on every one. 24/7.
Drop your logo on any product and see the virtual proof before asking. Quote routes direct to the desk. MCP catalog for AI agents. Celeste for the fast conversation. Full self-service checkout in development.